The global Bioengineered Artificial Skin Market Growth Accelerated by Rise in Burn Injuries and Trauma Cases


Bioengineered artificial skin products help regenerate skin tissues for patients suffering from severe burn injuries and trauma cases. They act as a protective barrier against infections and aid faster healing. The demand for artificial skin has increased in past years due to rise in burn injury cases associated with accidents at construction sites and households.

The global Bioengineered Artificial Skin Market is estimated to be valued at US$ 3.32 Bn in 2023 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Rise in burn injuries and trauma cases has been a major growth driver for this market. According to American Burn Association, around 450,000 burn injuries require medical treatment each year in the US alone. Biocompatible and biosynthetic nature of artificial skin allows it to integrate with the recipient bed and regenerate lost skin tissue matching the characteristics of normal skin. This property helps reduce scarring and disabilities related to large skin loss. Furthermore, advancement in materials science has improved the functionality of artificial skin to better mimic natural skin thereby accelerating wound healing process.


Segment Analysis

The global bioengineered artificial skin market can be segmented into autologous bioengineered skin substitutes and non-autologous bioengineered skin substitutes. The autologous bioengineered skin substitutes segment dominates the market as these products help achieve better cosmetic and functional outcomes. Autologous skin substitutes are prepared from a patient's own cells, reducing the risks of disease transmission and immune rejection.

Key Takeaways

The global bioengineered artificial skin market is expected to witness high growth. The market size for bioengineered artificial skin is projected to grow from US$ 3.32 Bn in 2023 to US$ 12.43 Bn by 2030, at a CAGR of 16%.

Regional analysis: North America currently dominates the bioengineered artificial skin market owing to high awareness regarding skin grafts and presence of advanced healthcare infrastructure. However, Asia Pacific is expected to witness the fastest growth during the forecast period due to rising incidences of burns and rapid development of healthcare facilities in emerging economies.

Key players: Key players operating in the bioengineered artificial skin market include Genoskin, Smith and Nephew Inc., Genzyme Biosurgery, Vericel Corporation, AROA BIOSURGERY LIMITED, Integra LifeSciences Corp, COOK BIOTECH, Mölnlycke Health Care AB, Avita Medical, MiMedx Group, Inc., and Organogenesis Holdings Inc. Genzyme Biosurgery and Integra LifeSciences Corp currently dominate the autologous skin substitutes segment.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more